Juris Pokrotnieks

Statistics

Publications

Citations

1.2K

H-Index

Active since

2005

Affiliations

Pauls Stradiņš Clinical University Hospital(Current)

Dr Falk Pharma (Germany)

University of Cologne

Riga Stradiņš University

Medical University of Vienna

Juris Pokrotnieks is an author at Pauls Stradiņš Clinical University Hospital specializing in pharmacotherapy, inflammatory bowel disease, and gastrointestinal pharmacotherapy.

ORCID

Publications per year

2005–2025

Publications

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Geert D’Haens, Marla C. Dubinsky, Taku Kobayashi et al. · New England Journal of Medicine · 2023 · 317 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

Wolfgang Kruis, Gediminas Kiudelis, I Rácz et al. · Gut · 2008 · 202 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +14

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis

Simon Bar–Meir, Alexandra Lavy, O Mickisch et al. · Alimentary Pharmacology & Therapeutics · 2005 · 95 citations · Full text

Nursing, Internal Medicine, Pharmacotherapy +17

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis

Wolfgang Kruis, Laimas Virginijus Jonaitis, Juris Pokrotnieks et al. · Alimentary Pharmacology & Therapeutics · 2010 · 80 citations

Pharmacy, Pharmacotherapy, Bowel Management +11

1–5 of 18